(-0.25%) 4 539.06 points
(0.64%) 35 656 points
(-0.80%) 14 144 points
(-2.53%) $75.89
(0.04%) $2.81
(0.60%) $2 059.30
(2.21%) $25.63
(-1.06%) 931.40
(0.71%) 0.918
(1.16%) 10.78
(0.55%) 0.792
(1.60%) 89.99
Live Chart Being Loaded With Signals
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract...
Stats | |
---|---|
Today's Volume | 212 523 |
Average Volume | 1.01M |
Market Cap | 1.67B |
EPS | $0 ( 2023-11-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.97 |
ATR14 | $0.140 (8.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-19 | Palihapitiya Chamath | Sell | 2 073 000 | Class A ordinary shares |
2023-11-15 | Palihapitiya Chamath | Sell | 282 300 | Class A ordinary shares |
2023-11-16 | Palihapitiya Chamath | Sell | 212 100 | Class A ordinary shares |
2023-11-17 | Palihapitiya Chamath | Sell | 258 400 | Class A ordinary shares |
2023-11-09 | Palihapitiya Chamath | Sell | 95 900 | Class A ordinary shares |
INSIDER POWER |
---|
51.80 |
Last 97 transactions |
Buy: 256 652 495 | Sell: 36 665 762 |
Volume Correlation
ProKidney Corp. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ProKidney Corp. Correlation - Currency/Commodity
ProKidney Corp. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.790 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.500 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.140 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.600 |
ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
AboutLive Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators